Employees: 856
Size Anhui Hongyu Wuzhou Medical Manufacturer (301234.SZ) is a China Health Care company (Medical Specialties) with a market value of $697M, the 2907th largest of 4,790 China companies the cockpit tracks. Shares closed at CN¥101.10 on 18 Nov 2026.
Performance Over six months the shares gained 148.0%, against -15.1% for the median peer and -20.0% for the China market (cap-weighted) — highest of 21 in its peer set.
Growth Revenue fell 14.0% over the last twelve months (peer median +14.8%); the operating margin is 3.2% (peer median 13.7%).
Valuation It trades at 10.3× enterprise value to sales against a peer median of 3.0× (2nd most expensive of 21).
Price implies For today's price to make sense, revenue must grow about 32% a year for seven years (Req g). Recent delivered growth is -1%, so the hurdle is +32 pp: the price needs faster growth than the company has been delivering — of companies that just grew 25–50% a year, 93.8% slowed down over the next four years.
Capital Return on invested capital runs 4.1 points above its cost of capital (5.0% WACC).
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | CN¥413M | CN¥457M | CN¥476M | CN¥533M | CN¥546M |
| Revenue growth | — | -4% | -11% | -2% | — |
| Gross profit | CN¥95.7M | CN¥61.4M | CN¥79.9M | CN¥109M | CN¥119M |
| EBITDA | n/a | CN¥54.3M | CN¥69.1M | CN¥86.6M | CN¥77.2M |
| Net income | CN¥17.9M | CN¥18.9M | CN¥40.0M | CN¥60.3M | CN¥70.9M |
| Free cash flow | CN¥14.4M | CN¥59.1M | CN¥53.7M | -CN¥18.9M | -CN¥53.0M |
| Capital expenditure | CN¥36.9M | CN¥19.8M | CN¥37.0M | CN¥70.9M | CN¥164M |
| Total debt | CN¥495,568 | CN¥680,413 | CN¥1.95M | CN¥782,956 | CN¥849,303 |
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
| Measure | 301234.SZ | Peer median | Rank in peer set |
|---|---|---|---|
| 1-month return | -23.9% | -7.3% | 3rd lowest of 21 |
| 6-month return | +148.0% | -15.1% | highest of 21 |
| Distance from 52-week high | -35.8% | -38.0% | 11th highest of 21 |
| Revenue growth (TTM) | -14.0% | +14.8% | 2nd lowest of 21 |
| Operating margin | 3.2% | 13.7% | 6th lowest of 21 |
| EV / Sales | 10.3× | 3.0× | 2nd most expensive of 21 |
| Growth the price implies (Req g, 7 yrs) | 31.8% | 6.6% | 2nd most demanding of 16 |
| Growth delivered (Del g) | -0.6% | +14.2% | 2nd lowest of 16 |
| Hurdle (Req g minus delivered) | +32.5 pp | -12.4 pp | most demanding of 16 |
| ROIC minus cost of capital | +4.1 pp | +2.3 pp | 9th highest of 21 |
| Company | Market | Market cap | 6M return | Revenue growth | Op. margin | EV / Sales | Req g | Delivered g |
|---|---|---|---|---|---|---|---|---|
| Anhui Hongyu Wuzhou Medical Manufacturer 301234.SZ | China | $697M | +148% | -14% | 3% | 10.3× | 31.8% | -0.6% |
| Shanghai INT Medical Instruments 1501.HK | Hong Kong | $700M | -25% | +35% | 21% | 3.6× | -3.3% | +23.5% |
| Shanghai Sanyou Medical 688085.SS | China | $692M | -23% | +15% | 4% | 7.1× | 29.0% | +6.8% |
| Japan Lifeline 7575.T | Japan | $703M | +34% | +6% | 19% | 1.7× | -9.5% | +2.9% |
| Shenzhen Lifotronic Technology 688389.SS | China | $692M | -14% | +14% | 13% | 3.0× | 11.6% | +13.3% |
| SWS Hemodialysis Care 688410.SS | China | $706M | -11% | +31% | 19% | 3.6× | 16.2% | +25.9% |
| Livsmed 491000.KS | South Korea | $687M | -47% | +89% | -77% | 18.1× | n/a | n/a |
| Doctorglasses Chain 300622.SZ | China | $710M | -22% | +6% | 14% | 3.1× | -3.4% | +15.7% |
| Delcath Systems DCTH | United States | $685M | +75% | +38% | 5% | 5.3× | 33.4% | +120.2% |
| Shenzhen Sunnypol Optoelectornics 002876.SZ | China | $680M | -9% | +29% | 5% | 1.6× | 10.1% | +14.2% |
| Caina Technology 301122.SZ | China | $721M | +36% | +61% | 0% | 7.7× | n/a | n/a |
| Shanghai Kinetic Medical 300326.SZ | China | $662M | -10% | -28% | 17% | 3.8× | 6.6% | -1.9% |
| Synektik SNT.WA | Poland | $662M | +10% | +32% | 24% | 2.9× | 0.2% | +47.5% |
| Shanghai Aladdin Biochemical Technology 688179.SS | China | $736M | -37% | +39% | 24% | 5.8× | 17.1% | +24.2% |
| BMC Medical 301367.SZ | China | $737M | -17% | +37% | 17% | 1.8× | -1.5% | +15.6% |
| Beijing Aerospace Changfeng 600855.SS | China | $738M | -44% | -10% | -19% | 4.5× | n/a | n/a |
| QuidelOrtho QDEL | United States | $657M | -20% | -5% | -2% | 1.4× | n/a | n/a |
| InMode INMD | United States | $741M | -8% | +2% | 18% | 0.6× | -10.8% | +12.4% |
| Shanghai Runda Medical Technology 603108.SS | China | $744M | -36% | -12% | -2% | 1.7× | 20.3% | -0.2% |
| Jiang Xi Sanxin Medtec 300453.SZ | China | $744M | -3% | +12% | 18% | 2.8× | -1.9% | +11.8% |
| Allmed Medical Products 002950.SZ | China | $747M | -32% | +14% | 8% | 1.5× | n/a | n/a |